Fig. 2From: Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancerElectropherogram showing unique profile of each of five different PDX models generated from SCLC. Note the identical STR profile of tumor samples harvested from animals bearing first generation (passage 1) and second generation (passage 2) PDXBack to article page